Effectiveness of the Natural Cycles birth control app

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-arm observational study in which participants use the Natural Cycles app for up to 13 cycles while logging daily sexual activity and menstrual/temperature data. Participants will perform urine pregnancy tests provided by mail at study entry, at the start of each cycle, and at exit, and will complete questionnaires at enrollment and study end. The study will calculate both typical-use pregnancy rates for all users and perfect-use pregnancy rates for users who follow the app's instructions exactly, using cycle-by-cycle data to meet regulatory standards. The design aims to overcome limitations of passive data collection by systematically capturing intercourse and pregnancy outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Wants to avoid pregnancy for 13 cycles.
* Is willing to rely solely on Natural Cycles as their sole contraception method for 13 cycles.
* Is not currently using permanent contraceptive methods, such as sterilization (of either the user or their partner), or hormonal methods, such as the hormonal contraceptive implant or IUD.
* Has an intact uterus, both ovaries and both fallopian tubes to the best of their knowledge.
* Has an average cycle length between 21 and 35 days. The user anticipates heterosexual intercourse at least once a month in the next year.
* Is willing to enter data on a daily basis and perform pregnancy tests as requested by protocol.
* Is willing to complete a satisfaction survey at the end of her study participation.

Exclusion Criteria:

* Has EU-citizenship
* Has had a Depo-Provera injection in the last 10 months or has had less than three consecutive, spontaneous menstrual cycles since their last injection.
* Has had less than three consecutive, spontaneous menstrual cycles after removing a hormonal implant.
* Has had less than three consecutive, spontaneous menstrual cycles after the end of a pregnancy.
* Has had less than three consecutive, spontaneous menstrual cycles since she last breastfed.
* Has (or partner has) known fertility issues, such as infertility and sterilization, or have been advised by a healthcare professional that they may have difficulty conceiving for any reason.
* Has a medical condition possibly impacting fertility, i.e. endometriosis, a history of Pelvic Inflammatory Disease (PID), significant uterine fibroids or adenomyosis, or another diagnosed medical condition that they have been told affects fertility.
* Is regularly taking one of the following prescribed pharmaceutical medications known to be teratogenic (i.e., a medication that can cause birth defects):

Isotretinoin (like Accutane, Absorica, Claravis, or Myorisan) for severe acne Valproic acid or divalproex sodium (like Depakote, Depakene, or Topamax) for seizures (epilepsy), migraines, or bipolar disorder Methotrexate (Trexall, Rheumatrex) or leflunomide (Arava) for autoimmune conditions ACE Inhibitors (like Lisinopril, Enalapril) or Angiotensin II Receptor Blockers (ARBs) (like Losartan, Valsartan) for high blood pressure or heart conditions Warfarin (Coumadin, Jantoven) for blood clot prevention

Where it's running

• Natural Cycles USA Corp
  New York, New York, United States Recruiting

Study contacts

• Principal investigator: Eleonora Benhar, PhD — Natural Cycles Nordic AB
• Study coordinator: Agathe van Lamsweerde, MSc
• Email: venus_study@naturalcycles.com
• Phone: 201-431-6036

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Female Reproductive Health in the Canadian Armed Forces: Understanding Issues from Contraception to Pelvic Floor Dysfunction

  This observational study looks at reproductive health among women in the Canadian Armed Forces to see how contraception, pregnancy outcomes, infertility, pelvic floor issues, and related factors affect service members and veterans.

  Recruiting Université de Sherbrooke · Sherbrooke, Quebec · NCT07524764

• Long-acting HIV PrEP and contraception PK study in AGYW

  This study tests how long-acting cabotegravir for PrEP interacts with hormonal contraception in young women.

  Recruiting University of Alabama at Birmingham · Bontleng, Gaborone · NCT07516548

• Vasectomy: Right for Me? — a web-based decision aid

  A web-based decision aid helps men think clearly about vasectomy and other birth control options to see if it fits their goals.

  Recruiting at 2 sites University of Pittsburgh · San Francisco, California and 1 other locations · NCT07451067

• Contraceptive patch designed to stop ovulation

  This trial tests whether a norelgestromin transdermal patch can keep ovulation suppressed for 84 days even when users make intentional application mistakes, in healthy women aged 18–35.

  Recruiting Phase 2 Viatris Inc. · Berlin · NCT07365904

• Helping teens and young adults choose menstrual care and birth control

  This project will try an Encounter Decision Aid to help adolescents and young adults (ages 12–25) make decisions about menstrual management and contraception during outpatient visits.

  Recruiting University Hospital, Geneva · Geneva, Canton of Geneva · NCT07320651

• Mittin intervention to improve contraceptive side effect counseling and follow-up in Addis Ababa

  Aims to see if the Mittin program helps women who use hormonal methods or copper IUDs in Addis Ababa better manage their contraception according to their preferences.

  Recruiting University of California, San Francisco · Addis Ababa · NCT07301281

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.